Several studies, including ours [48], demonstrated that RAC1 GTPase is upregulated/hyperactivated in breast cancer cells (in all three subsets like luminal, HER2-enriched, and TNBC) and is associated with poor prognosis. Here, ERBB2 is linked to breast cancer.